CSP
1 min read
19

Fondia Plc: Share repurchase 18.11.2024

November 18, 2024
0

Reading Time: < 1 minute Fondia Plc Company release 18.11.2024 at 6.45 p.m. EET   Fondia – Acquisition of own shares 18.11.2024   Fondia Plc   First North Finland   Date 18.11.2024 Exchange transactions Buy Share class FONDIA Amount, shares 160 Average price/share, EUR 6,00

Continue Reading
CSP
1 min read
13

#24-395 Listing of Derivatives at NGM

November 18, 2024
0

Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market

Continue Reading
CSP
1 min read
22

Nordea Bank Abp: Repurchase of own shares on 18.11.2024

November 18, 2024
0

Reading Time: < 1 minute Nordea Bank AbpStock exchange release – Changes in company’s own shares18.11.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 18.11.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average

Continue Reading
CSP
2 min read
18

Kesko Corporation: Disclosure in compliance with Chapter 9, Section 10 of the Finnish Securities Markets Act (15.11.2024)

November 18, 2024
0

Reading Time: 2 minutes Kesko Corporation has on 18 November 2024 received a notification pursuant to Chapter 9, Section 10 of the Finnish Securities Markets Act from BlackRock, Inc. According to the notification, on 15 November 2024, BlackRock, Inc.’s holding in Kesko Corporation, including holding

Continue Reading
ABS Reports Continued Fleet Growth and Industry Leading Safety Performance at Advisory Council
CSP
3 min read
16

ABS Reports Continued Fleet Growth and Industry Leading Safety Performance at Advisory Council

November 18, 2024
0

Reading Time: 2 minutes (NEW YORK) “Safety is more than just compliance. It is now synonymous with security, reliability, collective relationships and people. Safety is also becoming systems based rather than rooted in prescriptive rules or specific component procedures. Only by embracing a proactive, systems-oriented

Continue Reading
CSP
11 min read
24

OBSERVE MEDICAL ASA: Resolutions to increase the share capital in connection with subsequent offering and conditional loan conversion

November 18, 2024
0

Reading Time: 8 minutes NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT

Continue Reading
CSP
4 min read
15

Noble Corporation plc announces approval of request for removal from trading and official listing on Nasdaq Copenhagen

November 18, 2024
0

Reading Time: 3 minutes   SUGAR LAND, TEXAS, Nov. 18, 2024 /PRNewswire/ – Noble Corporation plc (“Noble“, the “Company“) (NYSE: NE, CSE: NOBLE) announces that today, Nasdaq Copenhagen A/S (“Nasdaq Copenhagen“) has approved Noble’s request for the voluntary removal of its shares (in the form of

Continue Reading
CSP
1 min read
13

#24-395 Listing of Derivatives at NGM

November 18, 2024
0

Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market

Continue Reading
CSP
3 min read
29

Company Update – Miton UK Microcap Trust Plc

November 18, 2024
0

Reading Time: 2 minutes NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THE JURISDICTION. THIS ANNOUNCEMENT CONTAINS INSIDE

Continue Reading
EQT Life Sciences leads €54 Million Series A Financing of ATB Therapeutics
CSP
4 min read
26

EQT Life Sciences leads €54 Million Series A Financing of ATB Therapeutics

November 18, 2024
0

Reading Time: 3 minutes Proceeds will fund clinical development of oncology and immunology therapeutics derived from innovative antibody payload platform Mark Throsby, industry veteran and former CSO of Merus, joins as Executive Chair EQT Life Sciences is pleased to announce that its LSP 7

Continue Reading